BackXPEL Overview

XPEL Current Cash

Track XPEL's current cash ($45M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$45.11M
↑ 91.61% YoYΔ $21.57M vs prior year quarter

Peer average

Loading

XPEL Current Cash History

Loading

XPEL vs. peers: Current Cash Comparison

Loading

XPEL Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

XPEL (XPEL) FAQ

XPEL (XPEL) currently reports a current cash of $45M as of March 2026. That compares with $24M in the prior-year period — up 91.6% year over year. Use the charts on this page to explore XPEL's current cash history and peer comparisons.

XPEL's current cash increased from $24M to $45M — a 91.6% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

XPEL reported $45M in current cash as of March 2026. That compares with $24M in the prior-year period — up 91.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $45M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for XPEL, and consider following XPEL for alerts when major investors trade the stock.

XPEL is classified in the Industrials sector. On current cash, it currently shows $45M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Industrials are usually more informative than comparing XPEL with unrelated industries.